Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mayr

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Chemsuschem|January 18, 2020
Response-Surface-Optimized and Scaled-Up Microbial Electrosynthesis of Chiral AlcoholsJeannine C Mayr, Luis F M Rosa, Natalia Klinger, et al.
Radiologie (Heidelberg, Germany)|April 10, 2026
[An unusual mass in the breast]A Ruiu, N Cortellini, S Stuppner, et al.
European Journal of Clinical Investigation|October 30, 1998
Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective studyN Reinisch, S Kiechl, C Mayr, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]A C Mayr, H J Senn, W M Gallmeier, et al.
European Journal of Medical Research|April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patientsH Knechten, C Stephan, F A Mosthaf, et al.
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|May 10, 2000
[Microbial emissions in collection of residential garbage]W Martens, R Böhm, A Fessel, et al.
European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.
Infection|March 31, 2010
Safety and efficacy of a saquinavir-containing antiretroviral regimen in previously ART-naïve or pretreated but protease inhibitor-naïve HIV-positive patientsH Knechten, C Stephan, F A Mosthaf, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Chemsuschem|January 18, 2020
Response-Surface-Optimized and Scaled-Up Microbial Electrosynthesis of Chiral AlcoholsJeannine C Mayr, Luis F M Rosa, Natalia Klinger, et al.
Radiologie (Heidelberg, Germany)|April 10, 2026
[An unusual mass in the breast]A Ruiu, N Cortellini, S Stuppner, et al.
European Journal of Clinical Investigation|October 30, 1998
Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective studyN Reinisch, S Kiechl, C Mayr, et al.
European Journal of Medical Research|July 2, 2011
Acute hepatitis C in persons infected with the human immunodeficiency virus (HIV): the "real-life setting" proves the conceptM Obermeier, P Ingiliz, L Weitner, et al.
Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.
Deutsche Medizinische Wochenschrift (1946)|December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]A C Mayr, H J Senn, W M Gallmeier, et al.
European Journal of Medical Research|April 14, 2011
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patientsH Knechten, C Stephan, F A Mosthaf, et al.
Schriftenreihe Des Vereins Fur Wasser-, Boden- Und Lufthygiene|May 10, 2000
[Microbial emissions in collection of residential garbage]W Martens, R Böhm, A Fessel, et al.
European Journal of Medical Research|October 19, 2010
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patientsC Stephan, H Jaeger, A Carganico, et al.
Infection|March 31, 2010
Safety and efficacy of a saquinavir-containing antiretroviral regimen in previously ART-naïve or pretreated but protease inhibitor-naïve HIV-positive patientsH Knechten, C Stephan, F A Mosthaf, et al.
Pageof 7